Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 2
2007 3
2010 1
2011 1
2012 1
2014 1
2017 3
2018 15
2019 3
2020 2
2021 2
2022 6
2023 6
2025 5
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Correction: Partially hydrolyzed, whey-based infant formula with six human milk oligosaccharides, B. infantis LMG11588, and B. lactis CNCM I-3446 is safe, well tolerated, and improves gut health: a staged analysis of a randomized trial.
Picaud JC, Claris O, Gil-Campos M, De La Cueva IS, Cornette L, Alliet P, Léké A, Castanet M, Piloquet H, de Halleux V, Mitanchez D, Vandenplas Y, Maton P, Jochum F, Olbertz D, Policarpo SN, Lavalle L, Fumero C, Rodriguez-Garcia P, Moll JM, Silva-Zolezzi I, Zemrani B, Hays NP, Sprenger N, Miranda-Mallea J. Picaud JC, et al. Among authors: jochum f. Front Nutr. 2025 Sep 12;12:1676657. doi: 10.3389/fnut.2025.1676657. eCollection 2025. Front Nutr. 2025. PMID: 41019559 Free PMC article.
Partially hydrolyzed, whey-based infant formula with six human milk oligosaccharides, B. infantis LMG11588, and B. lactis CNCM I-3446 is safe, well tolerated, and improves gut health: a staged analysis of a randomized trial.
Picaud JC, Claris O, Gil-Campos M, De La Cueva IS, Cornette L, Alliet P, Léké A, Castanet M, Piloquet H, de Halleux V, Mitanchez D, Vandenplas Y, Maton P, Jochum F, Olbertz D, Policarpo SN, Lavalle L, Fumero C, Rodriguez-Garcia P, Moll JM, Silva-Zolezzi I, Zemrani B, Hays NP, Sprenger N, Miranda-Mallea J. Picaud JC, et al. Among authors: jochum f. Front Nutr. 2025 Jul 23;12:1628847. doi: 10.3389/fnut.2025.1628847. eCollection 2025. Front Nutr. 2025. PMID: 40771223 Free PMC article.
180-day efficacy of nirsevimab against hospitalisation for respiratory syncytial virus lower respiratory tract infections in infants (HARMONIE): a randomised, controlled, phase 3b trial.
Munro APS, Drysdale SB, Cathie K, Flamein F, Knuf M, Collins AM, Hill HC, Kaiser F, Cohen R, Pinquier D, Vassilouthis NC, Carreno M, Moreau C, Bourron P, Marcelon L, Mari K, Roberts M, Tissières P, Royal S, Faust SN; HARMONIE Study Group. Munro APS, et al. Lancet Child Adolesc Health. 2025 Jun;9(6):404-412. doi: 10.1016/S2352-4642(25)00102-6. Lancet Child Adolesc Health. 2025. PMID: 40379431 Free article. Clinical Trial.
[Do basic welfare payments in Germany cover the food costs of a healthy diet for children and adolescents?].
Belgardt AJ, Kersting M, Sinningen K, Schmidt-Choudhury A, Jochum F, Claßen M, Lücke T. Belgardt AJ, et al. Among authors: jochum f. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2025 Feb;68(2):160-166. doi: 10.1007/s00103-024-04001-5. Epub 2025 Jan 14. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2025. PMID: 39808270 Free PMC article. German.
Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants.
Drysdale SB, Cathie K, Flamein F, Knuf M, Collins AM, Hill HC, Kaiser F, Cohen R, Pinquier D, Felter CT, Vassilouthis NC, Jin J, Bangert M, Mari K, Nteene R, Wague S, Roberts M, Tissières P, Royal S, Faust SN; HARMONIE Study Group. Drysdale SB, et al. N Engl J Med. 2023 Dec 28;389(26):2425-2435. doi: 10.1056/NEJMoa2309189. N Engl J Med. 2023. PMID: 38157500 Clinical Trial.
50 results